The pharmaceutical space is an area usually surrounded by confusion and controversy. Every day we hear horror stories about sky-high drug prices, patients priced out of life-saving medicines. What if the solution wasn't more regulation or government intervention, but something far simpler: competition? It's a concept as old as time,...
Competitor AstraZeneca is doubling down in China too, investing $2.5 billion into Beijing to establish a new R&D facility. This is not small potatoes, either. It’s a massive commitment that truly has the potential to turn the tides of the pharmaceutical landscape in China and around the world. Is it...
The pharmaceutical industry faces a period of seismic change, with much of the movement and play taking place in Asia. AstraZeneca’s recent performance and strategic moves paint a vivid picture of this trend. The company’s annual revenues exploded by an extraordinary 21%, soaring to £43 billion ($54.1 billion). This rapid...
British pharma-bulldozer AstraZeneca will pump $2.5 billion into a new research and development (R&D) hub. To be part of this ambitious journey that will lead to Beijing. This latest strategic move further highlights WuXi’s conviction to increase its foothold within China and continue to foster new, cutting-edge medicines. The Beijing...
We hear about it constantly. Famed for it being a leading indicator of economic prosperity, a weather vane on the roof of our national wallet. But is it really the gold standard, best measure ever, metrics by which all other metrics should be judged? As a journalist who has spent...
OverTraders.com just published a great in-depth Ethereum PoS vs Other Major Crypto PoS Models article. This side-by-side rundown helps shed light on the merits and demerits of each in different situations, providing critical information for traders and investors alike. Understanding Bitcoin and Ethereum To understand the nuances between different consensus...
Summary This piece dives deep into the startling effects of economic uncertainty on both mental health and consumer activity. This animated short dives into the psychological impact of recessions. Together, low consumer confidence and a fear of living in isolation can further increase stress, anxiety, and depression. By examining various...
Ever been sold your insurance policy as not just a safety net but a wise financial move, too? It’s a dangerous proposal, I recognize. Imagine the opportunity of having the benefit of protection along with the potential for financial growth. You’ll have a chance to hear directly about what’s new...
At the same time, the United States has increased its reliance on sanctions as a tool of foreign policy. Now, it focuses on individuals, countries and entities across the globe. These measures are put in place by the Office of Foreign Assets Control (OFAC). Their purpose is to shape behavior...
Artificial intelligence has gone from an imagined technological fantasy to an integral part of our everyday lives. From super-personalized recommendations on our separate site OverTraders.com to the algorithms that are reshaping our financial markets, AI’s influence can’t be overstated. This rapid integration comes with a chilling undercurrent: the potential for...
Obesity is the biggest threat to public health in the world, impacting nearly 650 million people worldwide. Yet it doesn’t stop there — the burden of transportation inequities weighs heavily on mental and emotional health. Real people are dealing with unfortunate obstacles while attempting to lose weight. As a result,...
The quick fix is perhaps the most potent temptation of all, particularly in the realm of weight loss. We know we’re all living in a world bombarded with images of unrealistic bodies. After all, the allure of losing weight with no effort — just a prescription — is difficult to...